ESR1 and breast cancer: For example, Tamoxifen (Td ER-positive: 0.294, Td ER-negative: 0.176), which is a selective estrogen receptor modulator, does not prevent ER-negative Breast Cancer, when the estrogen receptor genes do not express (Fabian, 2007; Uray and Brown, 2011).